Wikisage, the free encyclopedia of the second generation, is digital heritage
Epilepsy: Difference between revisions
mNo edit summary |
mNo edit summary |
||
Line 9: | Line 9: | ||
Morbility data is difficult to interpret when [[World Health Organization|WHO]]<ref>http://www.who.int/en/</ref> states 50-70 millions persons<ref>(Li et al 2014)</ref> suffers '''epilepsy'''<ref>(Chung 2015)</ref> | Morbility data is difficult to interpret when [[World Health Organization|WHO]]<ref>http://www.who.int/en/</ref> states 50-70 millions persons<ref>(Li et al 2014)</ref> suffers '''epilepsy'''<ref>(Chung 2015)</ref> | ||
nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance | nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance with [[antiepileptic drug|AED]]<ref>(Davis et al 2008)</ref> | ||
[[File: 1Eslicarbazepine acetate structure.svg.png|thumb|left|[[eslicarbazepine]]]] | [[File: 1Eslicarbazepine acetate structure.svg.png|thumb|left|[[eslicarbazepine]]]] | ||
{| class="toccolours float-right taxobox pilze" style="font-size:80%;" cellpadding="3" cellspacing="3" | {| class="toccolours float-right taxobox pilze" style="font-size:80%;" cellpadding="3" cellspacing="3" |
Revision as of 15:36, 16 April 2016
Classification of ethiology could divided in four categories:
- idiopathic epilepsy
- symptomatic epilepsy
- provoked epilepsy
- cryptogenic epilepsy
[1] It is difficult to distinguish between genetic and cryptogenic syndromes.
Morbility data is difficult to interpret when WHO[2] states 50-70 millions persons[3] suffers epilepsy[4]
nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance with AED[5]
Medicines | ||||
type | ,,, | ,,,, | ||
INN | Generic | slow release | ||
carbamazepine | normal | xr | ||
lamotrigine | normal | Lamictal XR[6] | ||
levetiracetam | normal | xr | ||
oxcarbazepine | ... | xr | ||
phenitoin | ... | xr | ||
valproate | xr | |||
topiramate | xr | |||
AED |
Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline
ILAE Classification
[7] [8] [9] [10] ILAE Overview
See also
A new perspective for Epileptic Disorders
Links
Epilepsies: diagnosis and management clinical guide
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population
The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
References: |
|